As per the data released by Ministry of Health and Family Welfare (MoHFW), India on March 07 reported single-day spike of 18,711 new coronavirus cases in the last 24 hours. 100 deaths in the same period pushed the COVID-19 toll in the country to 1,57,756. India's confirmed cases of coronavirus stand at 1,12,10,799 which include 1,84,523 active infections. More than 1,08,68,520 people have recovered from the virus with 14,392 new discharges in last 24 hours. Till date the total vaccination is 2,09,22,344. According to Indian Council of Medical Research (ICMR), a total of 7,37,830 samples were tested on March 06. Cumulative samples tested for COVID-19 till March 06 are 22,14,30,507.
According to the Health Ministry, total of 1,01,88,007 beneficiaries have been vaccinated in India for COVID-19 so far. India reported 13,193 new COVID-19 cases and 10,896 discharges on February 19. With new infections, the COVID tally of the country stood at 1,09,63,394 which includes 1,39,542 active cases. 1,06,67,741 patients have been discharged across the country. With 97 deaths in the last 24 hours, the death toll rose to 1,56,111.
Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.